Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years (Q45148605)
Jump to navigation
Jump to search
scientific article published in November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years |
scientific article published in November 2004 |
Statements
1 reference
Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years (English)
1 reference
Manfred P Wirth
1 reference
William A See
1 reference
David G McLeod
1 reference
Peter Iversen
1 reference
Tom Morris
1 reference
Kevin Carroll
1 reference
Casodex Early Prostate Cancer Trialists' Group
1 reference
1 November 2004
1 reference
1 reference
Identifiers
1 reference